Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EXERCISE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
EXERCISE is a concept in neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with Aging, Als, Alzheimer. Connected to 672 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | EXERCISE |
| Key Genes/Proteins | Actin, ADAM10, Adiponectin, ADRB2, AGING, AIM2 |
| Related Diseases | acetylcholine, Addiction, aging, Aging, Als |
| Related Pathways | Akt, Alpha-Synuclein |
Knowledge base pages for this entity
graph TD
EXERCISE["EXERCISE"]
EXERCISE -->|"inhibits"| BMAL1["BMAL1"]
EXERCISE -->|"inhibits"| TNF__["TNF-Alpha"]
EXERCISE -->|"activates"| BDNF["BDNF"]
EXERCISE -->|"activates"| PPARGC1A["PPARGC1A"]
EXERCISE -->|"activates"| LEARNING["LEARNING"]
EXERCISE -->|"activates"| MEMORY["MEMORY"]
EXERCISE -.protects against.-> depression["depression"]
EXERCISE -->|"activates"| serotonin["serotonin"]
CAV1["CAV1"] -->|"regulates"| EXERCISE
AMPK["AMPK"] -->|"regulates"| EXERCISE
SIRT1["SIRT1"] -->|"activates"| EXERCISE
FOXO1["FOXO1"] -->|"activates"| EXERCISE
P38["P38"] -->|"activates"| EXERCISE
CREB1["CREB1"] -->|"activates"| EXERCISE
PPARGC1A -->|"activates"| EXERCISE
PTEN["PTEN"] -->|"target for"| EXERCISE
AKT["AKT"] -->|"target for"| EXERCISE| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer | activates | disease | 1.00 |
| TNF-Α | inhibits | gene | 1.00 |
| Parkinson | activates | disease | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Aging | activates | disease | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| BDNF | activates | gene | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Insulin Resistance | activates | disease | 1.00 |
| Depression | therapeutic_target | disease | 1.00 |
| Als | activates | disease | 1.00 |
| BDNF | activates | protein | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| AMPK | activates | gene | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| Synaptic Plasticity | activates | pathway | 1.00 |
| PARKINSON | activates | gene | 1.00 |
| DEPRESSION | therapeutic_target | gene | 1.00 |
| Beta-Hydroxybutyrate | causes | compound | 0.95 |
| BMAL1 | inhibits | gene | 0.95 |
| AMPK | activates | protein | 0.95 |
| Neurodegeneration | therapeutic_target | disease | 0.95 |
| Mitochondria Dysfunction | modulates | mechanism | 0.95 |
| Endoplasmic Reticulum Stress | modulates | mechanism | 0.95 |
| Neurotrophic Factors | modulates | protein | 0.95 |
| Als | regulates | disease | 0.95 |
| Diabetes | activates | disease | 0.95 |
| Serotonin | upregulates | compound | 0.95 |
| BDNF | upregulates | protein | 0.95 |
| Parkinson'S Disease | protects_against | disease | 0.95 |
| Autophagy | modulates | process | 0.95 |
| Neurogenesis | upregulates | process | 0.90 |
| plasma NMN levels | increases | biomarker | 0.90 |
| Motor Function | associated_with | phenotype | 0.90 |
| neuroprotection | causes | phenotype | 0.90 |
| plasma NMN levels | associated_with | gene | 0.90 |
| Cognitive Function | associated_with | phenotype | 0.90 |
| Dopamine | upregulates | compound | 0.90 |
| Plasma NMN levels | associated_with | gene | 0.90 |
| FNDC5 | upregulates | protein | 0.90 |
| Inclusion Body Myositis | treats | disease | 0.90 |
| Cognition | associated_with | phenotype | 0.90 |
| IL-6 | activates | gene | 0.90 |
| BDNF | regulates | gene | 0.90 |
| Oxidative Stress | therapeutic_target | pathway | 0.90 |
| Source | Relation | Type | Str |
|---|---|---|---|
| OXIDATIVE STRESS | activates | gene | 1.00 |
| AGING | activates | gene | 1.00 |
| INSULIN RESISTANCE | activates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| 21768599 | increases | paper | 0.90 |
| 24120943 | induces | paper | 0.90 |
| 36511926 | did not result in significant differences in improvement in | paper | 0.90 |
| TNF | activates | gene | 0.90 |
| APOPTOSIS | activates | gene | 0.90 |
| SIRT1 | activates | gene | 0.90 |
| NEURODEGENERATION | therapeutic_target | gene | 0.90 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.90 |
| INFLAMMATION | activates | gene | 0.90 |
| PARKINSON'S DISEASE | activates | gene | 0.90 |
| DNA | activates | gene | 0.80 |
| FNDC5 | activates | gene | 0.80 |
| MITOCHONDRIAL DYSFUNCTION | therapeutic_target | gene | 0.80 |
| NRF2 | activates | gene | 0.80 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.80 |
| BDNF | activates | gene | 0.80 |
| PARKINSON'S DISEASE | associated_with | gene | 0.70 |
| NEURODEGENERATION | associated_with | gene | 0.70 |
| PINK1 | activates | gene | 0.70 |
| ANXIETY | therapeutic_target | gene | 0.70 |
| HUNTINGTON | activates | gene | 0.70 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.70 |
| TFAM | activates | gene | 0.70 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.70 |
| MITOPHAGY | activates | gene | 0.70 |
| TRKB | activates | gene | 0.70 |
| FOXO1 | activates | gene | 0.70 |
| NEURODEGENERATION | inhibits | gene | 0.70 |
| ALZHEIMER'S DISEASE | activates | gene | 0.70 |
| AGING | associated_with | gene | 0.70 |
| AGING | biomarker_for | gene | 0.70 |
| NF-ΚB | activates | gene | 0.70 |
| INFLAMMATION | associated_with | gene | 0.70 |
| GENES | activates | gene | 0.70 |
| TNF-Α | activates | gene | 0.70 |
| PARKINSON | activates | gene | 0.70 |
| AUTOPHAGY | regulates | gene | 0.70 |
| MITOPHAGY | therapeutic_target | gene | 0.70 |
| TAU | therapeutic_target | gene | 0.70 |
| INFLAMMATION | inhibits | gene | 0.70 |
| STROKE | regulates | gene | 0.60 |
| PIEZO1 | regulates | gene | 0.60 |
| MICROGLIA | regulates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| INSR | expressed_in | gene | 0.60 |
| APOPTOSIS | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| M1 Muscarinic Receptor Agonism as Pharmacological Exercise S | 0.589 | neurodegeneration | What are the specific circulating factor |
| Complement C1q Suppression as Mechanism Linking Exercise Pla | 0.560 | neurodegeneration | What are the specific circulating factor |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.589
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.552
neurodegeneration | 2026-04-13 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.50 · 2026-04-27
closed · Rounds: 4 · Score: 0.95 · 2026-04-16
closed · Rounds: 4 · Score: 0.58 · 2026-04-16
closed · Rounds: 4 · Score: 0.95 · 2026-04-15
Hypotheses and analyses mentioning EXERCISE in their description or question text
No additional research found